Medpace Holdings, Inc. (MEDP)

USD 331.0

(-5.02%)

Gross Profit Summary of Medpace Holdings, Inc.

  • Medpace Holdings, Inc.'s latest annual gross profit in 2023 was 524.5 Million USD , up 21.29% from previous year.
  • Medpace Holdings, Inc.'s latest quarterly gross profit in 2024 Q3 was 169 Million USD , up 15.28% from previous quarter.
  • Medpace Holdings, Inc. reported a annual gross profit of 432.43 Million USD in annual gross profit 2022, up 31.78% from previous year.
  • Medpace Holdings, Inc. reported a annual gross profit of 328.15 Million USD in annual gross profit 2021, up 17.73% from previous year.
  • Medpace Holdings, Inc. reported a quarterly gross profit of 146.6 Million USD for 2024 Q2, down -5.5% from previous quarter.
  • Medpace Holdings, Inc. reported a quarterly gross profit of 155.14 Million USD for 2024 Q1, up 13.4% from previous quarter.

Annual Gross Profit Chart of Medpace Holdings, Inc. (2023 - 2013)

Historical Annual Gross Profit of Medpace Holdings, Inc. (2023 - 2013)

Year Gross Profit Gross Profit Growth
2023 524.5 Million USD 21.29%
2022 432.43 Million USD 31.78%
2021 328.15 Million USD 17.73%
2020 278.72 Million USD 13.44%
2019 245.69 Million USD 14.0%
2018 215.53 Million USD 23.38%
2017 174.68 Million USD 1.5%
2016 172.11 Million USD 10.05%
2015 156.39 Million USD 16.95%
2014 133.73 Million USD 7.42%
2013 124.49 Million USD 0.0%

Peer Gross Profit Comparison of Medpace Holdings, Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD -5383.013%
Prenetics Global Limited 8.82 Million USD -5840.11%
Star Equity Holdings, Inc. 11.92 Million USD -4297.996%
CareDx, Inc 178.32 Million USD -194.129%
Exact Sciences Corporation 1.84 Billion USD 71.58%
Exagen Inc. 29.45 Million USD -1680.639%
Inotiv, Inc. 165.44 Million USD -217.031%
Guardant Health, Inc. 336.89 Million USD -55.688%
Biodesix, Inc. 36.07 Million USD -1353.849%
BioNexus Gene Lab Corp. 1.32 Million USD -39351.357%
Precipio, Inc. 6.01 Million USD -8615.603%
iSpecimen Inc. 5.1 Million USD -10168.473%
Natera, Inc. 492.74 Million USD -6.447%
Aspira Women's Health Inc. 5.26 Million USD -9867.788%
Standard BioTools Inc. 50.45 Million USD -939.653%
23andMe Holding Co. 99.37 Million USD -427.793%
Castle Biosciences, Inc. 174.8 Million USD -200.05%
Personalis, Inc. 18.2 Million USD -2780.629%
Aclaris Therapeutics, Inc. 13.16 Million USD -3883.179%
Applied DNA Sciences, Inc. 5.53 Million USD -9378.837%
OpGen, Inc. -90.69 Thousand USD 578423.814%
T2 Biosystems, Inc. -8.17 Million USD 6519.89%
Myriad Genetics, Inc. 476.4 Million USD -10.098%
ICON Public Limited Company 1.81 Billion USD 71.09%
NeoGenomics, Inc. 244.6 Million USD -114.43%
Star Equity Holdings, Inc. 11.92 Million USD -4297.996%
IDEXX Laboratories, Inc. 2.18 Billion USD 76.05%
RadNet, Inc. 93 Million USD -463.984%
MDxHealth SA 43.92 Million USD -1093.983%
Psychemedics Corporation 8.41 Million USD -6134.459%
Illumina, Inc. 2.74 Billion USD 80.885%
Check-Cap Ltd. -212 Thousand USD 247508.019%
Twist Bioscience Corporation 133.34 Million USD -293.333%
DarioHealth Corp. 5.98 Million USD -8665.124%
Fulgent Genetics, Inc. 104.45 Million USD -402.13%
Sera Prognostics, Inc. 96 Thousand USD -546259.375%
ENDRA Life Sciences Inc. -275.45 Thousand USD 190516.807%
OPKO Health, Inc. 318.12 Million USD -64.873%
Neogen Corporation 463.9 Million USD -13.064%
Intelligent Bio Solutions Inc. 1.42 Million USD -36691.206%
Prenetics Global Limited 8.82 Million USD -5840.11%
Mainz Biomed B.V. 509.65 Thousand USD -102812.928%
bioAffinity Technologies, Inc. 791.61 Thousand USD -66157.587%
Trinity Biotech plc 19.45 Million USD -2596.684%
Neuronetics, Inc. 51.7 Million USD -914.418%
Sotera Health Company 577.15 Million USD 9.123%
bioAffinity Technologies, Inc. 791.61 Thousand USD -66157.587%